3 completed. 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow DP-R208: new trials by email Literature Review of DP-R208 trials Research Report on DP-R208
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| DP-R208 Pharmacokinetic Study DP-R208, Candesartan cilexetil, Rosuvastatin - Healthy | Phase 1 | Completed | Alvogen Korea | 37 | 2016-03-01 | 2016-06-08 |
| Phase III Clinical Trial to Evaluate the Efficacy and Safety of DP-R208 and Each Monotherapy DP-R208, Candesartan32mg, Rosuvastatin 20mg - Hypertension, Cholesterolemia | Phase 3 | Completed | Alvogen Korea | 219 | 2015-12-01 | 2016-12-26 |
| Clinical Trial to Compare the Pharmacokinetics of DP-R208 DP-R208, Candesartan cilexetil, Rosuvastatin - Healthy | Phase 1 | Completed | Alvogen Korea | 40 | 2015-01-01 | 2016-03-23 |
Hypertension (1)
Alvogen Korea (3)
South Korea (1)
Changkyu Park (1) · Min-Gul Kim, Ph.D (1)